Share this
Turning Point Therapeutics to Sell to Bristol Myers Squibb for $4.1 Billion
June 3, 2022
Kite Pharma – $410 Million Shelf‑Takedown Offering
March 22, 2017
Cidara – $28 Million Follow-On Offering
October 21, 2016
Cidara Completes its Initial Public Offering
April 24, 2015
Sientra Completes Initial Public Offering
November 3, 2014
Ambit Biosciences to be Acquired by Daiichi Sankyo for $410 Million
October 2, 2014
Cooley Advises Kite Pharma on $146 Million Initial Public Offering
July 1, 2014
Cooley Represents Trius Therapeutics in Acquisition by Cubist Pharmaceuticals
August 5, 2013